Everolimus trials for Lung cancer

All Everolimus trials · All Lung cancer trials

Phase breakdown

Recruiting trials studying Everolimus for Lung cancer

• Efficacy and Safety of Radiotherapy Compared to Everolimus in Somatostatin Receptor Positive Neuroendocrine Tumors of the Lung and Thymus.
  NCT05918302 · Phase: Phase 3 · Ages: 18 Years and older · Sex: All (male and female) · 27 locations
• Safety and Durability of Sirolimus for Treatment of LAM
  NCT02432560 · Phase: Not specified · Ages: 18 Years and older · Sex: Female · 20 locations
• Testing Lutetium Lu 177 Dotatate in Patients With Somatostatin Receptor Positive Advanced Bronchial Neuroendocrine Tumors
  NCT04665739 · Phase: Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · 29 locations

Common questions

How many trials study Everolimus for Lung cancer?

3 recruiting trials.

Is this list complete?

No. For the full record, search ClinicalTrials.gov.